Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of ...

After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...

Lilly hopes that "patients see themselves reflected in the commercial," says Ashley Diaz-Granados, SVP of U.S. immunology ...

If your eczema is severe enough to warrant the use of a biologic, then you’ll most likely need lifelong treatment. There’s no cure for eczema. Most people with eczema benefit from the ...

Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that ...

This NIHR Collection brings together major studies on the prevention and treatment of childhood eczema. It finds that many ...

Contrary to some commonly held beliefs, current research shows that cutting out certain foods makes little difference in ...

The following is a summary of “Long-term safety and efficacy of delgocitinib cream for up to 52 weeks in adults with Chronic ...

A new survey commissioned by Leo Pharma confirms there’s plenty of room in the market for its chronic hand eczema treatment ...

Is your eczema mild, moderate, or severe? It’s not always an easy question to answer. The seriousness of eczema symptoms can vary a great deal between people. With mild eczema, you may have ...

Moderate to severe eczema can cover extensive parts of the skin, says Dr. Katherine Gordon, an associate professor of dermatology at UT Southwestern Medical Center. When eczema covers as much as ...